Global Blood Therapeutics Lands $40,700,000 Series A Financing

  • Feed Type
  • Date
    6/15/2012
  • Company Name
    Global Blood Therapeutics
  • Mailing Address
    455 Mission Bay Blvd South San Francisco, CA 94158
  • Company Description
    Global Blood Therapeutics, Inc. is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and severe genetic disorders for which there are currently no cures available and only extremely limited therapeutic options.
  • Website
    http://www.globalbloodtx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,700,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Undisclosed